Paper Details 
Original Abstract of the Article :
Patients who respond only partially to etanercept may require additional treatments that act synergistically to improve their therapeutic response while at the same time reducing the dose required and the risk of side-effects. The aim of this study was to evaluate the effecti veness of topical calci...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.2340/00015555-0585

データ提供:米国国立医学図書館(NLM)

Calcipotriol: A Synergistic Approach to Psoriasis Treatment

Psoriasis, a chronic skin condition, can be like a persistent sandstorm, leaving patients with itchy, scaly skin. This study explores the use of calcipotriol, a topical medication, in combination with etanercept, a biologic therapy, for patients with psoriasis. The study investigates the potential for a synergistic effect between these two treatments, aiming to improve overall treatment outcomes and reduce the risk of side effects.

A Combined Strategy for Effective Psoriasis Treatment

This study demonstrates the potential for a synergistic effect when combining calcipotriol and etanercept for the treatment of psoriasis. The study's findings suggest that this combination therapy may lead to more effective treatment outcomes, potentially improving symptom relief and reducing the need for higher doses of etanercept.

Navigating the Desert of Psoriasis

This research provides valuable insights into the treatment of psoriasis, highlighting the potential for a combined approach using calcipotriol and etanercept. The study's findings suggest that this combination therapy may offer a more effective and tolerable treatment option for patients with psoriasis, potentially improving overall outcomes and reducing the risk of side effects.

Dr.Camel's Conclusion

This study explores the synergistic potential of combining calcipotriol and etanercept for the treatment of psoriasis. The study's findings suggest that this combination therapy may offer a more effective and tolerable treatment option for patients with psoriasis, potentially leading to improved symptom relief and reduced side effects.
Date :
  1. Date Completed 2009-09-01
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

19479128

DOI: Digital Object Identifier

10.2340/00015555-0585

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.